Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Antagonist for Prevention of Early Ovarian Hyperstimulation Syndrome
NCT03188471Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of relugolix in ovarian hyperstimulation syndrome (OHSS), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
relugolix
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT03188471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188471.